Allergan

Allergan can do better than Valeant offer, investor says
Mass Device
Fri, 04/25/14 - 09:18 am
Valeant Pharmaceuticals
Allergan
M&A
Allergan sales force key to Valeant chief's plans for post-merger growth
Fierce Pharma Marketing
Thu, 04/24/14 - 11:32 am
Allergan
Valeant Pharmaceuticals
drug reps
M&A
[video] Why Is the Drug Industry in a Deal Frenzy?
Bloomberg
Thu, 04/24/14 - 07:31 am
M&A
Novartis
Valeant Pharmaceuticals
GSK
Eli Lilly
Allergan
Why Valeant International Inc. Is Acquiring Botox and Juvederm Maker Allergan
Motley Fool
Wed, 04/23/14 - 10:34 am
Valeant Pharmaceuticals
Allergan
M&A
medical aesthetics
Novartis, Valeant bids herald new deal-making era for pharma
Yahoo/Reuters
Wed, 04/23/14 - 08:30 am
Novartis
Valeant Pharmaceuticals
GSK
Eli Lilly
M&A
Allergan
With Big Pharma In Retreat, Ackman And Novartis Try A New Blueprint For Drug Companies
Forbes
Tue, 04/22/14 - 09:51 am
Novartis
M&A
GSK
Eli Lilly
Allergan
Valeant Pharmaceuticals
Billionaire Bill Ackman, Valeant Want To Takeover Botox-Maker Allergan
Forbes
Mon, 04/21/14 - 05:03 pm
Valeant Pharmaceuticals
M&A
Allergan
J&J says halting development of Botox rival
Yahoo/Reuters
Mon, 04/14/14 - 12:41 pm
JNJ
Botox
Allergan
PurTox
The Lesson of Allergan
TheStreet.com
Tue, 03/18/14 - 11:18 pm
Allergan
DARPin
macular degeneration
Health-Care Stocks: Growing Like Gangbusters
Motley Fool
Sat, 03/15/14 - 10:06 am
Regeneron
Sanofi
Gilead Sciences
Celgene
Allergan
Allergan Management Discusses Q4 2013 Results - Earnings Call Transcript
Seeking Alpha
Wed, 02/5/14 - 06:54 pm
earnings
Allergan
Allergan says decision on moving DARPin to phase 3 will be made on phase 2 data
Yahoo/Fly on the Wall
Wed, 02/5/14 - 02:53 pm
Allergan
DARPin
Allergan Slips on Restasis Challenge
Yahoo/Zacks.com
Thu, 01/23/14 - 05:54 pm
Allergan
Restasis
dry eye disease
Actavis
generics
Allergan rides high on patent backing for key drugs Lumigan and Restasis
Fierce Pharma
Thu, 01/16/14 - 06:54 am
Allergan
patents
Lumigan
Restasis
Allergan CEO preps multibillion-dollar deal spree to swell pipeline
Fierce Pharma
Wed, 01/15/14 - 09:52 am
Allergan
Pharma CEOs
David Pyott
Allergan completes sale of obesity intervention business
Yahoo/Fly on the Wall
Tue, 12/3/13 - 11:30 am
Allergan
M&A
Apollo Endosurgery
3 Profitable Pharmaceutical Stocks To Consider As Congress Debates Drug Bill
TheStreet.com
Fri, 11/15/13 - 11:54 am
Forest Labs
Allergan
Bristol-Myers Squibb
Allergan Agrees to Sell Obesity Unit; 3rd-Quarter Profit Up 20%
NASDAQ.com
Tue, 10/29/13 - 10:02 am
Allergan
obesity
earnings
M&A
Apollo Endosurgery
Top 10 Drug Patent Losses of 2014
Fierce Pharma
Mon, 10/28/13 - 10:26 am
patents
Copaxone
Teva
Nexium
AstraZeneca
Micardis
Boehringer Ingelheim
Sandostatin LAR
Novartis
Exforge
Nasonex
Merck
TriLipix
AbbVie
Evista
Eli Lilly
Restasis
Allergan
Renagel
Sanofi
Allergan (AGN) Earnings Projected to Increase
Forbes
Fri, 10/25/13 - 10:19 am
Allergan
earnings

Pages